UPDATE 1-Roche confirms 2021 outlook as diagnostics sales mitigate COVID-19 drug slump – Reuters

UPDATE 1-Roche confirms 2021 outlook as diagnostics sales mitigate COVID-19 drug slump – Reuters

Swiss drugmaker Roche on Wednesday stuck to its 2021 forecast for revenue growth, as its first-quarter sales of COVID-19 diagnostics helped offset a deepening slump in the mainstay drug business that has been crimped by the pandemic.

Read More…

You May Also Like